annual cash & cash equivalents:
$122.72M+$38.41M(+45.56%)Summary
- As of today (August 4, 2025), ATRC annual cash & cash equivalents is $122.72 million, with the most recent change of +$38.41 million (+45.56%) on December 31, 2024.
- During the last 3 years, ATRC annual cash & cash equivalents has risen by +$79.07 million (+181.12%).
- ATRC annual cash & cash equivalents is now at all-time high.
Performance
ATRC Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$117.80M+$17.91M(+17.93%)Summary
- As of today (August 4, 2025), ATRC quarterly cash & cash equivalents is $117.80 million, with the most recent change of +$17.91 million (+17.93%) on June 30, 2025.
- Over the past year, ATRC quarterly cash & cash equivalents has increased by +$11.76 million (+11.09%).
- ATRC quarterly cash & cash equivalents is now -9.62% below its all-time high of $130.34 million, reached on September 30, 2024.
Performance
ATRC quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ATRC Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +45.6% | +11.1% |
| 3 y3 years | +181.1% | +115.9% |
| 5 y5 years | +330.9% | +33.1% |
ATRC Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +181.1% | -9.6% | +141.3% |
| 5 y | 5-year | at high | +330.9% | -9.6% | +318.6% |
| alltime | all time | at high | +2800.7% | -9.6% | >+9999.0% |
ATRC Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $117.80M(+17.9%) |
| Mar 2025 | - | $99.89M(-18.6%) |
| Dec 2024 | $122.72M(+45.6%) | $122.72M(-5.8%) |
| Sep 2024 | - | $130.34M(+22.9%) |
| Jun 2024 | - | $106.03M(+63.2%) |
| Mar 2024 | - | $64.97M(-22.9%) |
| Dec 2023 | $84.31M(+45.1%) | $84.31M(+4.6%) |
| Sep 2023 | - | $80.60M(+19.9%) |
| Jun 2023 | - | $67.24M(-13.1%) |
| Mar 2023 | - | $77.34M(+33.1%) |
| Dec 2022 | $58.10M(+33.1%) | $58.10M(+19.0%) |
| Sep 2022 | - | $48.82M(-10.5%) |
| Jun 2022 | - | $54.56M(+93.9%) |
| Mar 2022 | - | $28.14M(-35.5%) |
| Dec 2021 | $43.65M(+4.1%) | $43.65M(+9.4%) |
| Sep 2021 | - | $39.89M(-41.0%) |
| Jun 2021 | - | $67.62M(-20.8%) |
| Mar 2021 | - | $85.38M(+103.6%) |
| Dec 2020 | $41.94M(+47.3%) | $41.94M(+25.7%) |
| Sep 2020 | - | $33.38M(-62.3%) |
| Jun 2020 | - | $88.52M(+306.7%) |
| Mar 2020 | - | $21.77M(-23.6%) |
| Dec 2019 | $28.48M(-11.6%) | $28.48M(-14.2%) |
| Sep 2019 | - | $33.18M(+31.4%) |
| Jun 2019 | - | $25.25M(+21.8%) |
| Mar 2019 | - | $20.72M(-35.7%) |
| Dec 2018 | $32.23M(+47.8%) | $32.23M(+79.1%) |
| Sep 2018 | - | $18.00M(+29.8%) |
| Jun 2018 | - | $13.87M(-34.7%) |
| Mar 2018 | - | $21.23M(-2.7%) |
| Dec 2017 | $21.81M(-9.9%) | $21.81M(+12.2%) |
| Sep 2017 | - | $19.44M(-7.5%) |
| Jun 2017 | - | $21.01M(+9.7%) |
| Mar 2017 | - | $19.15M(-20.9%) |
| Dec 2016 | $24.21M(+1.9%) | $24.21M(+50.3%) |
| Sep 2016 | - | $16.11M(-19.1%) |
| Jun 2016 | - | $19.92M(-4.1%) |
| Mar 2016 | - | $20.77M(-12.6%) |
| Dec 2015 | $23.76M | $23.76M(-17.2%) |
| Sep 2015 | - | $28.71M(-4.2%) |
| Jun 2015 | - | $29.99M(+27.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $23.56M(-17.0%) |
| Dec 2014 | $28.38M(+90.6%) | $28.38M(-20.1%) |
| Sep 2014 | - | $35.53M(-15.4%) |
| Jun 2014 | - | $41.98M(-38.8%) |
| Mar 2014 | - | $68.64M(+360.9%) |
| Dec 2013 | $14.89M(+92.1%) | $14.89M(-42.3%) |
| Sep 2013 | - | $25.82M(-16.8%) |
| Jun 2013 | - | $31.04M(+0.8%) |
| Mar 2013 | - | $30.78M(+297.1%) |
| Dec 2012 | $7.75M(-20.6%) | $7.75M(-5.5%) |
| Sep 2012 | - | $8.20M(-5.3%) |
| Jun 2012 | - | $8.66M(-24.2%) |
| Mar 2012 | - | $11.42M(+17.0%) |
| Dec 2011 | $9.76M(+130.7%) | $9.76M(+184.4%) |
| Sep 2011 | - | $3.43M(-16.5%) |
| Jun 2011 | - | $4.11M(-46.5%) |
| Mar 2011 | - | $7.69M(+81.7%) |
| Dec 2010 | $4.23M(-52.5%) | $4.23M(+20.0%) |
| Sep 2010 | - | $3.53M(-48.6%) |
| Jun 2010 | - | $6.85M(+87.5%) |
| Mar 2010 | - | $3.66M(-59.0%) |
| Dec 2009 | $8.91M(-22.2%) | $8.91M(-15.8%) |
| Sep 2009 | - | $10.57M(-23.0%) |
| Jun 2009 | - | $13.73M(+59.5%) |
| Mar 2009 | - | $8.61M(-24.8%) |
| Dec 2008 | $11.45M(-11.9%) | $11.45M(-6.8%) |
| Sep 2008 | - | $12.28M(+22.5%) |
| Jun 2008 | - | $10.02M(-23.0%) |
| Mar 2008 | - | $13.01M(+0.1%) |
| Dec 2007 | $13.00M(-12.7%) | $13.00M(-24.5%) |
| Sep 2007 | - | $17.23M(-37.9%) |
| Jun 2007 | - | $27.74M(+110.3%) |
| Mar 2007 | - | $13.19M(-11.4%) |
| Dec 2006 | $14.89M(-45.7%) | $14.89M(-5.9%) |
| Sep 2006 | - | $15.82M(-20.2%) |
| Jun 2006 | - | $19.81M(-14.1%) |
| Mar 2006 | - | $23.06M(-15.9%) |
| Dec 2005 | $27.43M(+430.1%) | $27.43M(-28.4%) |
| Sep 2005 | - | $38.34M(+3414.8%) |
| Jun 2005 | - | $1.09M(-55.5%) |
| Mar 2005 | - | $2.45M(-52.6%) |
| Dec 2004 | $5.18M | $5.18M |
FAQ
- What is AtriCure, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AtriCure, Inc.?
- What is AtriCure, Inc. annual cash & cash equivalents year-on-year change?
- What is AtriCure, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for AtriCure, Inc.?
- What is AtriCure, Inc. quarterly cash & cash equivalents year-on-year change?
What is AtriCure, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of ATRC is $122.72M
What is the all time high annual cash & cash equivalents for AtriCure, Inc.?
AtriCure, Inc. all-time high annual cash & cash equivalents is $122.72M
What is AtriCure, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, ATRC annual cash & cash equivalents has changed by +$38.41M (+45.56%)
What is AtriCure, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ATRC is $117.80M
What is the all time high quarterly cash & cash equivalents for AtriCure, Inc.?
AtriCure, Inc. all-time high quarterly cash & cash equivalents is $130.34M
What is AtriCure, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, ATRC quarterly cash & cash equivalents has changed by +$11.76M (+11.09%)